{"gene":"CLU","run_date":"2026-04-28T17:28:52","timeline":{"discoveries":[{"year":1988,"finding":"SP-40,40 (CLU/clusterin) is incorporated into the SC5b-9 soluble membrane attack complex of complement, functioning as an inhibitor of complement-mediated cytolysis by combining with the nascent C5b-7 complex to form a cytolytically inactive SC5b-7–SP-40,40 complex","method":"Protein purification, hemolysis inhibition assay, immunodepletion of SP-40,40 from serum followed by SC5b-9 reconstitution","journal":"The Journal of clinical investigation / International immunology","confidence":"High","confidence_rationale":"Tier 1 — in vitro functional reconstitution and inhibition assay, replicated across multiple labs (PMID:2454950, 2489042, 2150757)","pmids":["2454950","2489042","2150757"],"is_preprint":false},{"year":1989,"finding":"The two chains (alpha and beta) of SP-40,40/CLU are encoded in a single open reading frame on the same mRNA and are generated post-synthetically by proteolytic cleavage of a biosynthetic precursor that contains a signal sequence for secretory export and six N-linked glycosylation sites","method":"cDNA cloning and sequence analysis, molecular characterization","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — direct molecular cloning and sequence determination of precursor structure","pmids":["2721499"],"is_preprint":false},{"year":1991,"finding":"SP-40,40/CLU is associated with high-density lipoproteins (HDL) in human plasma, with up to 40–60% of NA1/NA2 (SP-40,40) co-eluting with apolipoprotein A-I-containing HDL fractions","method":"Agarose gel filtration, FPLC, anti-apoA-I immunoaffinity chromatography, partial amino acid sequencing","journal":"Arteriosclerosis and thrombosis","confidence":"Medium","confidence_rationale":"Tier 2 — multiple chromatographic methods in single lab","pmids":["1903064"],"is_preprint":false},{"year":1992,"finding":"All 10 cysteine residues of SP-40,40/CLU form interchain (alpha–beta) disulfide bonds arranged in an antiparallel ladder-like structure; no free sulfhydryl groups are present, and the disulfide bond motif is unique among complement proteins","method":"Tryptic peptide mapping, HPLC separation, amino acid sequencing of disulfide-containing peptides, fluorometric detection with ABD-F","journal":"FEBS letters / Journal of biochemistry","confidence":"High","confidence_rationale":"Tier 1 — direct biochemical determination of disulfide bonds by peptide mapping and sequencing, confirmed by two independent studies","pmids":["1551440","1491011"],"is_preprint":false},{"year":1993,"finding":"Soluble amyloid-beta (Abeta) in cerebrospinal fluid is complexed with SP-40,40/CLU (apolipoprotein J) in vivo; the interaction was demonstrated by direct binding experiments with synthetic Abeta peptide and immunoprecipitation from CSF","method":"Direct binding assay with synthetic Abeta peptide, immunoprecipitation from CSF, amino acid sequencing, immunoreactivity with specific antibodies","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 — in vitro direct binding plus in vivo immunoprecipitation from CSF","pmids":["8328966"],"is_preprint":false},{"year":2015,"finding":"Three patient-specific CLU mutations in the beta-chain (p.I303NfsX13, p.R338W, p.I360N) cause retention of CLU protein in the endoplasmic reticulum, reduced Golgi transport, and diminished secretion, demonstrating that the beta-chain disulfide bridge region is required for CLU heterodimerization and transit through the secretory pathway","method":"Immunocytochemistry, immunodetection, ELISA for secreted CLU, expression in HEK293T and HEK293 FLp-In cell lines","journal":"Molecular neurodegeneration","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (ICC, Western, ELISA) in two cell lines with multiple mutations","pmids":["26179372"],"is_preprint":false},{"year":2016,"finding":"TREM2 directly binds CLU/APOJ (and other apolipoproteins) as identified by unbiased protein microarray screen; TREM2 overexpression enhances CLU uptake in heterologous cells, Trem2 knockout microglia show reduced CLU internalization, and disease-associated TREM2 mutations impair this binding and uptake","method":"Protein microarray screen, Co-immunoprecipitation, cell uptake assays in heterologous cells and primary microglia, Trem2 knockout mouse microglia, human macrophages from TREM2 variant carriers","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 — unbiased screen plus multiple orthogonal functional validation methods across cell types and human samples","pmids":["27477018"],"is_preprint":false},{"year":2011,"finding":"EZH2 directly represses CLU expression in neuroblastoma cells via H3K27me3 deposition at the CLU gene locus; EZH2 knockdown or pharmacological inhibition restores CLU expression, and EZH2-/- MEFs show elevated CLU mRNA","method":"RNAi knockdown of EZH2, pharmacological inhibition with 3-deazaneplanocin A, HDAC inhibitor treatment, ChIP for H3K27me3 and PRC2 components at CLU locus, comparison with EZH2-/- MEFs","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal approaches (RNAi, pharmacology, ChIP, genetic KO) in same study","pmids":["22068036"],"is_preprint":false},{"year":2011,"finding":"Secreted CLU (sCLU) activates AKT survival signaling, whereas intracellular CLU inhibits NF-κB transcriptional activity; intracellular CLU forms a physical complex with HSP60 in neuroblastoma cells, and HSP60 inactivates the tumor-suppressive function of intracellular CLU","method":"Immunoprecipitation (physical complex with HSP60), AKT activity assay, NF-κB reporter assay, subcellular fractionation, overexpression of secreted vs. intracellular CLU forms","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2–3 — single lab with Co-IP and functional reporter assays","pmids":["22012253"],"is_preprint":false},{"year":2002,"finding":"Transient CLU overexpression in SV40-immortalized human prostate epithelial cells (PNT2) causes accumulation in G0/G1, slows cell cycle progression, decreases DNA synthesis, reduces ODC and AdoMetDC activities, and increases Gas1 mRNA, demonstrating a direct anti-proliferative function","method":"Transient transfection/overexpression, flow cytometry cell cycle analysis, [3H]-thymidine incorporation, enzyme activity assays, Northern blot","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 — clean gain-of-function with multiple readouts in single lab","pmids":["12082621"],"is_preprint":false},{"year":2023,"finding":"CLU promotes mitophagy in oral cancer stem cells by activating AKT, which phosphorylates DNM1L/Drp1 at Ser616 to initiate mitochondrial fission; CLU-mediated mitophagy degrades MSX2, preventing its nuclear translocation and thereby sustaining SOX2-dependent stemness. CLU knockdown disrupts mitochondrial metabolism and sensitizes cells to cisplatin","method":"Gain-of-function and loss-of-function (CLU overexpression and shRNA knockdown), phospho-specific western blot for DNM1L-Ser616, mitophagy flux assays, mitochondrial superoxide measurement, nuclear/cytoplasmic fractionation for MSX2, SOX2 reporter, xenograft models","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods (KO/OE, phospho-WB, fractionation) in single lab","pmids":["36779631"],"is_preprint":false},{"year":2023,"finding":"SORL1 loss in human iPSC-derived neurons (but not astrocytes, microglia, or endothelial cells) causes a cell-type-specific reduction in CLU protein levels; this neuron-specific SORL1–CLU relationship is validated in postmortem brain. TGF-β/SMAD signaling modulates APOE (and by implication CLU) levels in a SORL1-dependent manner","method":"SORL1-null iPSC differentiation to multiple cell types, proteomics, ELISA, retromer rescue experiments, SMAD pathway modulation, postmortem brain validation","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 — multiple cell types and orthogonal validation including postmortem brain, single lab","pmids":["37611586"],"is_preprint":false},{"year":2023,"finding":"The CLU rs11136000 C risk allele is a functional variant: TDP-43 preferentially binds the C allele to promote CLU expression; C/C astrocytes show elevated interferon response and CXCL10 secretion after cytokine treatment, which inhibits oligodendrocyte progenitor cell (OPC) proliferation and myelination","method":"CRISPR-Cas9 isogenic iPSC system, allele-specific TDP-43 binding assay, RNA-seq, CXCL10 ELISA, OPC co-culture myelination assay, human brain tissue validation","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1–2 — isogenic CRISPR system with multiple functional readouts and human brain validation","pmids":["37494190"],"is_preprint":false},{"year":2025,"finding":"CLU deficiency in astrocytes activates NF-κB-dependent signaling and increases complement C3 secretion; reduced astrocyte CLU leads to microglia-dependent reduction of synaptic density, increased microglial phagocytosis, and altered extracellular APOE and phospho-tau levels. CLU AD-risk alleles associate with reduced CLU protein and heightened inflammatory profiles in human plasma and brain","method":"Unbiased proteomics in CLU-deficient astrocytes, functional validation (NF-κB reporter, C3 ELISA), microglia-astrocyte co-culture synapse counting, phagocytosis assay, mouse models, human plasma and brain tissue analysis","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 1–2 — unbiased proteomics plus multiple orthogonal functional assays across mouse and human systems","pmids":["40311610"],"is_preprint":false},{"year":1991,"finding":"Clusterin (SGP-2) is secreted into the caput epididymal lumen, binds to spermatozoa in the caput, and then dissociates from sperm to be endocytosed by cells of the distal epididymal epithelium; testicular and epididymal forms differ in molecular weight and isoelectric point","method":"Micropuncture/microperfusion collection of luminal fluid, 2D Western blot, membrane protein extraction from spermatozoa at different epididymal regions","journal":"Molecular reproduction and development","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization by fractionation and binding assay tied to functional implications in sperm maturation","pmids":["1781989"],"is_preprint":false},{"year":1999,"finding":"Extracellular CLU/SGP-2 acts as a mediator of anti-TNF-induced cytotoxicity: exogenous SGP-2 reduces TNF sensitivity in LNCaP cells, and anti-SGP-2 antibody renders TNF-resistant PC3 cells sensitive to TNF-induced cell death; this effect is reversible by adding exogenous SGP-2","method":"Cell viability assay (trypan blue), antibody neutralization of secreted SGP-2, exogenous protein addition, Western blot of conditioned media","journal":"The Prostate","confidence":"Medium","confidence_rationale":"Tier 3 — single lab, antibody neutralization + rescue experiment with defined cellular phenotype","pmids":["10221563"],"is_preprint":false}],"current_model":"CLU (clusterin/apolipoprotein J/SP-40,40) is a secreted heterodimeric glycoprotein generated by proteolytic cleavage of a single-chain precursor; its alpha and beta chains are linked by a unique interchain disulfide ladder. Extracellularly, sCLU inhibits complement membrane-attack complex assembly, binds HDL and apolipoproteins, and is taken up by microglia via TREM2-dependent recognition of CLU-lipoprotein complexes; sCLU also complexes soluble amyloid-beta in CSF and activates AKT to promote cell survival. In astrocytes, CLU suppresses NF-κB/C3-dependent inflammatory signaling and limits microglial phagocytosis of synapses, with its expression regulated by TDP-43 binding to the rs11136000 risk allele and epigenetically silenced by EZH2. Intracellularly, CLU can be retained in the nucleus or ER, where it inhibits NF-κB, forms a complex with HSP60 that modulates its tumor-suppressive function, or—when mutated in its beta-chain disulfide region—is degraded rather than secreted. In cancer stem cells, CLU activates AKT→DNM1L/Drp1 Ser616 phosphorylation to drive mitophagy, thereby degrading MSX2 and sustaining SOX2-dependent stemness."},"narrative":{"teleology":[{"year":1988,"claim":"Establishing CLU's first known function: the question of what SP-40,40 does in serum was answered by showing it inhibits complement-mediated cytolysis by incorporating into the soluble membrane-attack complex and inactivating nascent C5b-7.","evidence":"Protein purification, hemolysis inhibition assay, and immunodepletion/reconstitution of SC5b-9 from human serum","pmids":["2454950","2489042","2150757"],"confidence":"High","gaps":["Structural basis of C5b-7 recognition unknown","In vivo complement-regulatory role not demonstrated at this point","Stoichiometry of SP-40,40 in SC5b-9 complex not fully defined"]},{"year":1989,"claim":"The biosynthetic origin of CLU's two-chain structure was resolved: a single mRNA encodes both alpha and beta chains as a precursor that undergoes post-translational cleavage and N-linked glycosylation for secretory export.","evidence":"cDNA cloning and full-length sequence analysis from human liver","pmids":["2721499"],"confidence":"High","gaps":["Identity of the processing protease unknown","Signals governing glycosylation site occupancy not characterized"]},{"year":1991,"claim":"Two new biological contexts for CLU were established: association with HDL in plasma implicated CLU in lipoprotein metabolism, and its dynamic binding/release cycle on spermatozoa in the epididymis revealed a role in reproductive biology.","evidence":"FPLC/immunoaffinity chromatography of plasma lipoproteins; micropuncture/microperfusion and 2D Western blot of epididymal luminal fluid","pmids":["1903064","1781989"],"confidence":"Medium","gaps":["Functional consequence of HDL association for lipid transport unclear","Whether CLU on spermatozoa influences fertilization not tested","Receptor mediating epididymal re-uptake unknown"]},{"year":1992,"claim":"The unique disulfide architecture of CLU was mapped: all 10 cysteines form interchain alpha–beta bonds in an antiparallel ladder, with no free sulfhydryls, establishing a structural hallmark distinct from other complement-associated proteins.","evidence":"Tryptic peptide mapping, HPLC, amino acid sequencing of disulfide peptides","pmids":["1551440","1491011"],"confidence":"High","gaps":["No three-dimensional structure available","Functional role of individual disulfide bonds not dissected"]},{"year":1993,"claim":"CLU was linked to Alzheimer's disease biology by demonstrating that soluble amyloid-beta in CSF is physically complexed with CLU, establishing CLU as an endogenous Aβ-binding chaperone.","evidence":"Direct binding assay with synthetic Aβ peptide and co-immunoprecipitation from human CSF","pmids":["8328966"],"confidence":"High","gaps":["Whether CLU-Aβ complexation prevents or promotes amyloid deposition in vivo unknown","Binding stoichiometry and affinity not quantified","Receptor-mediated clearance of CLU-Aβ complex not identified"]},{"year":1999,"claim":"Extracellular CLU was shown to confer cytoprotection against TNF-induced cell death: neutralizing secreted CLU sensitized resistant cancer cells to TNF, and exogenous CLU reversed this effect.","evidence":"Antibody neutralization of secreted CLU, exogenous protein rescue, cell viability assay in prostate cancer lines","pmids":["10221563"],"confidence":"Medium","gaps":["Downstream signaling pathway mediating anti-TNF effect not identified","Whether this reflects a general anti-apoptotic function or TNF-specific mechanism unclear"]},{"year":2002,"claim":"A direct anti-proliferative function for CLU was demonstrated: overexpression caused G0/G1 arrest, reduced DNA synthesis, and upregulated growth arrest gene Gas1, extending CLU's role beyond secreted chaperone to cell-autonomous growth regulation.","evidence":"Transient transfection in PNT2 prostate epithelial cells, flow cytometry, thymidine incorporation, enzyme activity assays","pmids":["12082621"],"confidence":"Medium","gaps":["Mechanism linking CLU to Gas1 upregulation unknown","Whether the anti-proliferative effect requires secreted or intracellular CLU not distinguished"]},{"year":2011,"claim":"Two studies resolved how CLU expression is regulated and how its secreted vs. intracellular forms differ functionally: EZH2 directly silences CLU via H3K27me3, while sCLU activates AKT and intracellular CLU inhibits NF-κB in a complex with HSP60.","evidence":"ChIP for H3K27me3/PRC2 at CLU locus with EZH2 knockdown/knockout; Co-IP of CLU-HSP60, AKT activity assay, NF-κB reporter assay in neuroblastoma cells","pmids":["22068036","22012253"],"confidence":"High","gaps":["Identity of kinase(s) downstream of sCLU-AKT activation unknown","Physiological relevance of CLU-HSP60 complex outside neuroblastoma not tested","Whether EZH2-mediated silencing operates in neurons or astrocytes unknown"]},{"year":2015,"claim":"The functional requirement of the beta-chain disulfide region for CLU secretion was demonstrated: patient-derived mutations in this region cause ER retention and abolish heterodimerization, linking structural integrity to secretory pathway transit.","evidence":"Expression of three CLU point mutants in HEK293T/Flp-In cells, ICC co-localization with ER markers, ELISA for secreted CLU","pmids":["26179372"],"confidence":"High","gaps":["Whether ER-retained CLU triggers unfolded protein response not examined","In vivo consequences of these mutations in patient brain tissue not characterized"]},{"year":2016,"claim":"The receptor mediating microglial uptake of CLU was identified as TREM2: TREM2 directly binds CLU, Trem2 knockout microglia show impaired CLU internalization, and AD-associated TREM2 variants disrupt this interaction.","evidence":"Protein microarray screen, Co-IP, cell uptake assays in Trem2-KO primary microglia and human TREM2-variant macrophages","pmids":["27477018"],"confidence":"High","gaps":["Whether TREM2-CLU interaction mediates Aβ clearance in vivo not demonstrated","Structural basis of TREM2-CLU binding not resolved","Contribution of other receptors (e.g., megalin/LRP2) to CLU uptake not excluded"]},{"year":2023,"claim":"Three studies expanded CLU's mechanistic repertoire: in cancer stem cells CLU drives AKT→DNM1L/Drp1-dependent mitophagy to sustain SOX2 stemness; SORL1 controls neuron-specific CLU levels; and the AD-risk SNP rs11136000 C allele enhances CLU expression via TDP-43 binding, leading to astrocytic interferon/CXCL10 signaling that impairs myelination.","evidence":"CLU gain/loss-of-function with phospho-Drp1 and mitophagy flux assays in oral cancer stem cells and xenografts; SORL1-null iPSC-derived neurons with proteomics and postmortem validation; CRISPR-isogenic iPSC astrocytes with allele-specific TDP-43 binding, RNA-seq, and OPC co-culture myelination assay","pmids":["36779631","37611586","37494190"],"confidence":"Medium","gaps":["Whether AKT-Drp1-mitophagy axis operates outside oral cancer not tested","Mechanism by which SORL1 regulates CLU protein specifically in neurons unclear","TDP-43 binding to rs11136000 not validated in vivo"]},{"year":2025,"claim":"CLU's neuroinflammatory function was mechanistically defined: CLU deficiency in astrocytes activates NF-κB, elevates complement C3 secretion, and drives microglia-dependent synaptic loss via enhanced phagocytosis, directly linking reduced CLU to AD-related neurodegeneration.","evidence":"Unbiased proteomics in CLU-deficient astrocytes, NF-κB reporter, C3 ELISA, astrocyte-microglia co-culture synapse counting, mouse models, human plasma/brain validation","pmids":["40311610"],"confidence":"High","gaps":["Whether CLU supplementation can rescue synaptic loss in vivo not shown","Specific NF-κB subunit(s) regulated by CLU not identified","Relative contribution of complement-dependent vs. independent microglial phagocytosis pathways not dissected"]},{"year":null,"claim":"Key unresolved questions include the three-dimensional structure of CLU, the identity of the protease that cleaves the precursor into alpha/beta chains, the full receptor repertoire for CLU uptake across cell types, and whether restoring CLU levels in astrocytes or neurons can ameliorate neurodegeneration in vivo.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal or cryo-EM structure of CLU heterodimer","Processing protease identity unknown","Therapeutic potential of CLU modulation untested in neurodegeneration models"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,8,13]},{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[4]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[2]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,2,4,14,15]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[5]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[8]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,13]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[8,10]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[10]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[15]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[2]}],"complexes":["SC5b-9 (soluble membrane attack complex)","HDL particle","CLU-HSP60 complex"],"partners":["TREM2","HSP60","TDP-43","SORL1","DNM1L","AKT1"],"other_free_text":[]},"mechanistic_narrative":"CLU (clusterin/apolipoprotein J/SP-40,40) is a secreted heterodimeric glycoprotein chaperone that functions as a broad extracellular proteostasis and cytoprotective factor, with roles spanning complement regulation, lipoprotein metabolism, amyloid-beta clearance, and neuroinflammatory control. The mature protein is generated by proteolytic cleavage of a single-chain precursor into disulfide-linked alpha and beta chains arranged in a unique antiparallel disulfide ladder; mutations in the beta-chain disulfide region cause ER retention and loss of secretion [PMID:2721499, PMID:1551440, PMID:26179372]. Extracellularly, sCLU inhibits complement membrane-attack complex assembly by sequestering nascent C5b-7, associates with HDL, complexes soluble amyloid-beta in CSF, activates AKT survival signaling, and is internalized by microglia via TREM2 [PMID:2454950, PMID:1903064, PMID:8328966, PMID:22012253, PMID:27477018]. In astrocytes, CLU suppresses NF-κB/complement C3-dependent inflammatory signaling to limit microglial synaptic phagocytosis, with its expression regulated by TDP-43 binding at the AD-risk SNP rs11136000 and epigenetically silenced by EZH2-mediated H3K27 trimethylation [PMID:40311610, PMID:37494190, PMID:22068036]."},"prefetch_data":{"uniprot":{"accession":"P10909","full_name":"Clusterin","aliases":["Aging-associated gene 4 protein","Apolipoprotein J","Apo-J","Complement cytolysis inhibitor","CLI","Complement-associated protein SP-40,40","Ku70-binding protein 1","NA1/NA2","Sulfated glycoprotein 2","SGP-2","Testosterone-repressed prostate message 2","TRPM-2"],"length_aa":449,"mass_kda":52.5,"function":"Functions as extracellular chaperone that prevents aggregation of non native proteins (PubMed:11123922, PubMed:19535339). Prevents stress-induced aggregation of blood plasma proteins (PubMed:11123922, PubMed:12176985, PubMed:17260971, PubMed:19996109). Inhibits formation of amyloid fibrils by APP, APOC2, B2M, CALCA, CSN3, SNCA and aggregation-prone LYZ variants (in vitro) (PubMed:12047389, PubMed:17407782, PubMed:17412999). Does not require ATP (PubMed:11123922). Maintains partially unfolded proteins in a state appropriate for subsequent refolding by other chaperones, such as HSPA8/HSC70 (PubMed:11123922). Does not refold proteins by itself (PubMed:11123922). Binding to cell surface receptors triggers internalization of the chaperone-client complex and subsequent lysosomal or proteasomal degradation (PubMed:21505792). Protects cells against apoptosis and against cytolysis by complement: inhibits assembly of the complement membrane attack complex (MAC) by preventing polymerization of C9 pore component of the MAC complex (PubMed:2780565, PubMed:1903064, PubMed:2601725, PubMed:2721499, PubMed:1551440, PubMed:9200695, PubMed:34667172). Intracellular forms interact with ubiquitin and SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complexes and promote the ubiquitination and subsequent proteasomal degradation of target proteins (PubMed:20068069). Promotes proteasomal degradation of COMMD1 and IKBKB (PubMed:20068069). Modulates NF-kappa-B transcriptional activity (PubMed:12882985). A mitochondrial form suppresses BAX-dependent release of cytochrome c into the cytoplasm and inhibit apoptosis (PubMed:16113678, PubMed:17689225). Plays a role in the regulation of cell proliferation (PubMed:19137541). An intracellular form suppresses stress-induced apoptosis by stabilizing mitochondrial membrane integrity through interaction with HSPA5 (PubMed:22689054). Secreted form does not affect caspase or BAX-mediated intrinsic apoptosis and TNF-induced NF-kappa-B-activity (PubMed:24073260). Secreted form act as an important modulator during neuronal differentiation through interaction with STMN3 (By similarity). Plays a role in the clearance of immune complexes that arise during cell injury (By similarity) Does not affect caspase or BAX-mediated intrinsic apoptosis and TNF-induced NF-kappa-B-activity Does not affect caspase or BAX-mediated intrinsic apoptosis and TNF-induced NF-kappa-B-activity (PubMed:24073260). Promotes cell death through interaction with BCL2L1 that releases and activates BAX (PubMed:21567405)","subcellular_location":"Nucleus; Cytoplasm; Mitochondrion membrane; Cytoplasm, cytosol; Microsome; Endoplasmic reticulum; Mitochondrion; Mitochondrion membrane; Cytoplasm, perinuclear region; Cytoplasmic vesicle, secretory vesicle, chromaffin granule","url":"https://www.uniprot.org/uniprotkb/P10909/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CLU","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CANX","stoichiometry":0.2},{"gene":"CCAR1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/CLU","total_profiled":1310},"omim":[{"mim_id":"616990","title":"CLUSTERIN-LIKE PROTEIN 1; CLUL1","url":"https://www.omim.org/entry/616990"},{"mim_id":"616787","title":"CLUSTERIN-ASSOCIATED PROTEIN 1; CLUAP1","url":"https://www.omim.org/entry/616787"},{"mim_id":"605086","title":"TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; TREM2","url":"https://www.omim.org/entry/605086"},{"mim_id":"600073","title":"LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 2; LRP2","url":"https://www.omim.org/entry/600073"},{"mim_id":"600040","title":"BCL2-ASSOCIATED X PROTEIN; BAX","url":"https://www.omim.org/entry/600040"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"liver","ntpm":9103.3}],"url":"https://www.proteinatlas.org/search/CLU"},"hgnc":{"alias_symbol":["SGP-2","SP-40","TRPM-2","KUB1","CLU1","CLU2"],"prev_symbol":["CLI","APOJ"]},"alphafold":{"accession":"P10909","domains":[{"cath_id":"-","chopping":"26-58_381-449","consensus_level":"medium","plddt":82.1815,"start":26,"end":449},{"cath_id":"-","chopping":"78-191_278-374","consensus_level":"medium","plddt":88.8687,"start":78,"end":374}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P10909","model_url":"https://alphafold.ebi.ac.uk/files/AF-P10909-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P10909-F1-predicted_aligned_error_v6.png","plddt_mean":77.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CLU","jax_strain_url":"https://www.jax.org/strain/search?query=CLU"},"sequence":{"accession":"P10909","fasta_url":"https://rest.uniprot.org/uniprotkb/P10909.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P10909/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P10909"}},"corpus_meta":[{"pmid":"19734902","id":"PMC_19734902","title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.","date":"2009","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19734902","citation_count":2296,"is_preprint":false},{"pmid":"19734903","id":"PMC_19734903","title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease.","date":"2009","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19734903","citation_count":2002,"is_preprint":false},{"pmid":"27477018","id":"PMC_27477018","title":"TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia.","date":"2016","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/27477018","citation_count":715,"is_preprint":false},{"pmid":"2477686","id":"PMC_2477686","title":"Induction of the TRPM-2 gene in cells undergoing programmed death.","date":"1989","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/2477686","citation_count":456,"is_preprint":false},{"pmid":"2454950","id":"PMC_2454950","title":"SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis.","date":"1988","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/2454950","citation_count":306,"is_preprint":false},{"pmid":"8328966","id":"PMC_8328966","title":"The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex.","date":"1993","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/8328966","citation_count":270,"is_preprint":false},{"pmid":"2721499","id":"PMC_2721499","title":"Molecular cloning and characterization of the novel, human complement-associated protein, SP-40,40: a link between the complement and reproductive systems.","date":"1989","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/2721499","citation_count":238,"is_preprint":false},{"pmid":"21379329","id":"PMC_21379329","title":"Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE.","date":"2011","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21379329","citation_count":202,"is_preprint":false},{"pmid":"20554627","id":"PMC_20554627","title":"Replication of CLU, CR1, and PICALM associations with alzheimer disease.","date":"2010","source":"Archives of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/20554627","citation_count":178,"is_preprint":false},{"pmid":"7680346","id":"PMC_7680346","title":"Genomic organization and expression of the rat TRPM-2 (clusterin) gene, a gene implicated in apoptosis.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7680346","citation_count":177,"is_preprint":false},{"pmid":"9815554","id":"PMC_9815554","title":"Intracellular levels of SGP-2 (Clusterin) correlate with tumor grade in prostate cancer.","date":"1997","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/9815554","citation_count":158,"is_preprint":false},{"pmid":"22068036","id":"PMC_22068036","title":"EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR.","date":"2011","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/22068036","citation_count":153,"is_preprint":false},{"pmid":"1373021","id":"PMC_1373021","title":"SP-40,40 is a constituent of Alzheimer's amyloid.","date":"1992","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/1373021","citation_count":147,"is_preprint":false},{"pmid":"21543606","id":"PMC_21543606","title":"Common Alzheimer's disease risk variant within the CLU gene affects white matter microstructure in young adults.","date":"2011","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/21543606","citation_count":145,"is_preprint":false},{"pmid":"8181474","id":"PMC_8181474","title":"Molecular characterization of human TRPM-2/clusterin, a gene associated with sperm maturation, apoptosis and neurodegeneration.","date":"1994","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8181474","citation_count":141,"is_preprint":false},{"pmid":"8132868","id":"PMC_8132868","title":"Clusterin (SGP-2): a multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain.","date":"1994","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/8132868","citation_count":138,"is_preprint":false},{"pmid":"10815883","id":"PMC_10815883","title":"Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo.","date":"2000","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/10815883","citation_count":136,"is_preprint":false},{"pmid":"26150027","id":"PMC_26150027","title":"Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.","date":"2015","source":"Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica","url":"https://pubmed.ncbi.nlm.nih.gov/26150027","citation_count":118,"is_preprint":false},{"pmid":"2185274","id":"PMC_2185274","title":"Human seminal clusterin (SP-40,40). Isolation and characterization.","date":"1990","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/2185274","citation_count":115,"is_preprint":false},{"pmid":"1864465","id":"PMC_1864465","title":"The SGP-2 gene is developmentally regulated in the mouse kidney and abnormally expressed in collecting duct cysts in polycystic kidney disease.","date":"1991","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/1864465","citation_count":109,"is_preprint":false},{"pmid":"3415696","id":"PMC_3415696","title":"Rat clusterin isolated from primary Sertoli cell-enriched culture medium is sulfated glycoprotein-2 (SGP-2).","date":"1988","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/3415696","citation_count":104,"is_preprint":false},{"pmid":"1919566","id":"PMC_1919566","title":"Lack of correspondence between mRNA expression for a putative cell death molecule (SGP-2) and neuronal cell death in the central nervous system.","date":"1991","source":"Journal of neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/1919566","citation_count":101,"is_preprint":false},{"pmid":"14618611","id":"PMC_14618611","title":"Clusterin (SGP-2, ApoJ) expression is downregulated in low- and high-grade human prostate cancer.","date":"2004","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/14618611","citation_count":88,"is_preprint":false},{"pmid":"7870303","id":"PMC_7870303","title":"Selective expression of clusterin (SGP-2) and complement C1qB and C4 during responses to neurotoxins in vivo and in vitro.","date":"1994","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/7870303","citation_count":83,"is_preprint":false},{"pmid":"1626310","id":"PMC_1626310","title":"Possible functions of a new genetic marker in central nervous system: the sulfated glycoprotein-2 (SGP-2).","date":"1992","source":"Synapse (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/1626310","citation_count":79,"is_preprint":false},{"pmid":"26673020","id":"PMC_26673020","title":"The CLU-files: disentanglement of a mystery.","date":"2016","source":"Biomolecular concepts","url":"https://pubmed.ncbi.nlm.nih.gov/26673020","citation_count":78,"is_preprint":false},{"pmid":"2489042","id":"PMC_2489042","title":"SP-40,40 is an inhibitor of C5b-6-initiated haemolysis.","date":"1989","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/2489042","citation_count":77,"is_preprint":false},{"pmid":"12082621","id":"PMC_12082621","title":"Clusterin (SGP-2) transient overexpression decreases proliferation rate of SV40-immortalized human prostate epithelial cells by slowing down cell cycle progression.","date":"2002","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/12082621","citation_count":74,"is_preprint":false},{"pmid":"1903064","id":"PMC_1903064","title":"Characterization of a human high density lipoprotein-associated protein, NA1/NA2. Identity with SP-40,40, an inhibitor of complement-mediated cytolysis.","date":"1991","source":"Arteriosclerosis and thrombosis : a journal of vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/1903064","citation_count":74,"is_preprint":false},{"pmid":"22248099","id":"PMC_22248099","title":"Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased Alzheimer risk.","date":"2012","source":"Molecular neurodegeneration","url":"https://pubmed.ncbi.nlm.nih.gov/22248099","citation_count":71,"is_preprint":false},{"pmid":"9601101","id":"PMC_9601101","title":"The S. cerevisiae CLU1 and D. discoideum cluA genes are functional homologues that influence mitochondrial morphology and distribution.","date":"1998","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/9601101","citation_count":68,"is_preprint":false},{"pmid":"1895664","id":"PMC_1895664","title":"SGP-2 expression as a genetic marker of progressive cellular pathology in experimental hydronephrosis.","date":"1991","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/1895664","citation_count":68,"is_preprint":false},{"pmid":"22795969","id":"PMC_22795969","title":"Alzheimer risk variant CLU and brain function during aging.","date":"2012","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/22795969","citation_count":66,"is_preprint":false},{"pmid":"8263017","id":"PMC_8263017","title":"Gp80 (clusterin; TRPM-2) mRNA level is enhanced in human renal clear cell carcinomas.","date":"1994","source":"Journal of cancer research and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/8263017","citation_count":65,"is_preprint":false},{"pmid":"10221563","id":"PMC_10221563","title":"Cytotoxic sensitivity to tumor necrosis factor-alpha in PC3 and LNCaP prostatic cancer cells is regulated by extracellular levels of SGP-2 (clusterin).","date":"1999","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/10221563","citation_count":64,"is_preprint":false},{"pmid":"2150757","id":"PMC_2150757","title":"Incorporation of SP-40,40 into the soluble membrane attack complex (SMAC, SC5b-9) of complement.","date":"1990","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/2150757","citation_count":64,"is_preprint":false},{"pmid":"1551440","id":"PMC_1551440","title":"SP-40,40, a protein involved in the control of the complement pathway, possesses a unique array of disulphide bridges.","date":"1992","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/1551440","citation_count":64,"is_preprint":false},{"pmid":"2045098","id":"PMC_2045098","title":"The gene for SP-40,40, human homolog of rat sulfated glycoprotein 2, rat clusterin, and rat testosterone-repressed prostate message 2, maps to chromosome 8.","date":"1991","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/2045098","citation_count":62,"is_preprint":false},{"pmid":"8911667","id":"PMC_8911667","title":"Monitoring the temporal and spatial activation pattern of astrocytes in focal cerebral ischemia using in situ hybridization to GFAP mRNA: comparison with sgp-2 and hsp70 mRNA and the effect of glutamate receptor antagonists.","date":"1996","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/8911667","citation_count":61,"is_preprint":false},{"pmid":"20570404","id":"PMC_20570404","title":"Association of CLU and PICALM variants with Alzheimer's disease.","date":"2010","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/20570404","citation_count":60,"is_preprint":false},{"pmid":"22234156","id":"PMC_22234156","title":"Association of TCF4 and CLU polymorphisms with Fuchs' endothelial dystrophy and implication of CLU and TGFBI proteins in the disease process.","date":"2012","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/22234156","citation_count":60,"is_preprint":false},{"pmid":"1749509","id":"PMC_1749509","title":"Sulfated glycoprotein-2 (SGP-2) mRNA is expressed in rat striatal astrocytes following ibotenic acid lesions.","date":"1991","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/1749509","citation_count":58,"is_preprint":false},{"pmid":"2483750","id":"PMC_2483750","title":"Localization of terminal complement components S-protein and SP-40,40 in renal biopsies.","date":"1989","source":"Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/2483750","citation_count":58,"is_preprint":false},{"pmid":"1491011","id":"PMC_1491011","title":"Identification of the disulfide bonds in human plasma protein SP-40,40 (apolipoprotein-J).","date":"1992","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1491011","citation_count":58,"is_preprint":false},{"pmid":"2391426","id":"PMC_2391426","title":"Sandwich ELISA assay for quantitative measurement of SP-40,40 in seminal plasma and serum.","date":"1990","source":"Journal of immunological methods","url":"https://pubmed.ncbi.nlm.nih.gov/2391426","citation_count":58,"is_preprint":false},{"pmid":"20739100","id":"PMC_20739100","title":"Genetic variations in the CLU and PICALM genes are associated with cognitive function in the oldest old.","date":"2010","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/20739100","citation_count":57,"is_preprint":false},{"pmid":"8407000","id":"PMC_8407000","title":"Mitotic activity, apoptosis and TRPM-2 mRNA expression in DMBA-induced rat mammary carcinoma treated with anti-estrogen toremifene.","date":"1993","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/8407000","citation_count":57,"is_preprint":false},{"pmid":"27229352","id":"PMC_27229352","title":"Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27229352","citation_count":55,"is_preprint":false},{"pmid":"11375906","id":"PMC_11375906","title":"Up-regulation of TRPM-2, MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in the Noble rat.","date":"2001","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/11375906","citation_count":54,"is_preprint":false},{"pmid":"23892938","id":"PMC_23892938","title":"The CLU gene rs11136000 variant is significantly associated with Alzheimer's disease in Caucasian and Asian populations.","date":"2013","source":"Neuromolecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23892938","citation_count":52,"is_preprint":false},{"pmid":"20599866","id":"PMC_20599866","title":"Implication of CLU gene polymorphisms in Chinese patients with Alzheimer's disease.","date":"2010","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20599866","citation_count":52,"is_preprint":false},{"pmid":"24643340","id":"PMC_24643340","title":"Genotype patterns at CLU, CR1, PICALM and APOE, cognition and Mediterranean diet: the PREDIMED-NAVARRA trial.","date":"2014","source":"Genes & nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/24643340","citation_count":51,"is_preprint":false},{"pmid":"19878770","id":"PMC_19878770","title":"Chapter 2: Clusterin (CLU): From one gene and two transcripts to many proteins.","date":"2009","source":"Advances in cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19878770","citation_count":50,"is_preprint":false},{"pmid":"10923795","id":"PMC_10923795","title":"Purification, characterization, and molecular cloning of acidophilic xylanase from penicillium sp.40.","date":"2000","source":"Bioscience, biotechnology, and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10923795","citation_count":50,"is_preprint":false},{"pmid":"20209083","id":"PMC_20209083","title":"Genetic variability in CLU and its association with Alzheimer's disease.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20209083","citation_count":49,"is_preprint":false},{"pmid":"24806679","id":"PMC_24806679","title":"Combined effects of Alzheimer risk variants in the CLU and ApoE genes on ventricular expansion patterns in the elderly.","date":"2014","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24806679","citation_count":47,"is_preprint":false},{"pmid":"26179372","id":"PMC_26179372","title":"Reduced secreted clusterin as a mechanism for Alzheimer-associated CLU mutations.","date":"2015","source":"Molecular neurodegeneration","url":"https://pubmed.ncbi.nlm.nih.gov/26179372","citation_count":46,"is_preprint":false},{"pmid":"37611586","id":"PMC_37611586","title":"Cell-type-specific regulation of APOE and CLU levels in human neurons by the Alzheimer's disease risk gene SORL1.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37611586","citation_count":43,"is_preprint":false},{"pmid":"7755847","id":"PMC_7755847","title":"Evidence for activation of the terminal pathway of complement and upregulation of sulfated glycoprotein (SGP)-2 in the hypoglossal nucleus following peripheral nerve injury.","date":"1995","source":"Molecular and chemical neuropathology","url":"https://pubmed.ncbi.nlm.nih.gov/7755847","citation_count":43,"is_preprint":false},{"pmid":"19879423","id":"PMC_19879423","title":"Clusterin (CLU) and lung cancer.","date":"2009","source":"Advances in cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19879423","citation_count":42,"is_preprint":false},{"pmid":"19879422","id":"PMC_19879422","title":"CLU and colon cancer. The dual face of CLU: from normal to malignant phenotype.","date":"2009","source":"Advances in cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19879422","citation_count":40,"is_preprint":false},{"pmid":"24660791","id":"PMC_24660791","title":"The benefits of staying active in old age: physical activity counteracts the negative influence of PICALM, BIN1, and CLU risk alleles on episodic memory functioning.","date":"2014","source":"Psychology and aging","url":"https://pubmed.ncbi.nlm.nih.gov/24660791","citation_count":40,"is_preprint":false},{"pmid":"7558712","id":"PMC_7558712","title":"Photoreceptor cells in the vitiligo mouse die by apoptosis. TRPM-2/clusterin expression is increased in the neural retina and in the retinal pigment epithelium.","date":"1995","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/7558712","citation_count":38,"is_preprint":false},{"pmid":"1718280","id":"PMC_1718280","title":"Studies on the relationship between cell proliferation and cell death: opposite patterns of SGP-2 and ornithine decarboxylase mRNA accumulation in PHA-stimulated human lymphocytes.","date":"1991","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/1718280","citation_count":38,"is_preprint":false},{"pmid":"22012253","id":"PMC_22012253","title":"The tumour-suppressive function of CLU is explained by its localisation and interaction with HSP60.","date":"2011","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/22012253","citation_count":37,"is_preprint":false},{"pmid":"28428074","id":"PMC_28428074","title":"Melittin inhibits tumor growth and decreases resistance to gemcitabine by downregulating cholesterol pathway gene CLU in pancreatic ductal adenocarcinoma.","date":"2017","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/28428074","citation_count":36,"is_preprint":false},{"pmid":"19879420","id":"PMC_19879420","title":"Clusterin (CLU) and prostate cancer.","date":"2009","source":"Advances in cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19879420","citation_count":35,"is_preprint":false},{"pmid":"8549673","id":"PMC_8549673","title":"A ribonucleotide reductase inhibitor, MDL 101,731, induces apoptosis and elevates TRPM-2 mRNA levels in human prostate tumor xenografts.","date":"1996","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/8549673","citation_count":35,"is_preprint":false},{"pmid":"9665473","id":"PMC_9665473","title":"Lack of association between enhanced TRPM-2/clusterin expression and increased apoptotic activity in sex-hormone-induced prostatic dysplasia of the Noble rat.","date":"1998","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/9665473","citation_count":35,"is_preprint":false},{"pmid":"9010356","id":"PMC_9010356","title":"Effects of intermittent androgen suppression on the stem cell composition and the expression of the TRPM-2 (clusterin) gene in the Shionogi carcinoma.","date":"1996","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9010356","citation_count":35,"is_preprint":false},{"pmid":"32991610","id":"PMC_32991610","title":"Lower DNA methylation levels in CpG island shores of CR1, CLU, and PICALM in the blood of Japanese Alzheimer's disease patients.","date":"2020","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/32991610","citation_count":34,"is_preprint":false},{"pmid":"7605616","id":"PMC_7605616","title":"Increased TRPM-2/clusterin mRNA levels during the time of retinal degeneration in mouse models of retinitis pigmentosa.","date":"1994","source":"Biochemistry and cell biology = Biochimie et biologie cellulaire","url":"https://pubmed.ncbi.nlm.nih.gov/7605616","citation_count":34,"is_preprint":false},{"pmid":"25633098","id":"PMC_25633098","title":"CLU rs9331888 Polymorphism Contributes to Alzheimer's Disease Susceptibility in Caucasian But Not East Asian Populations.","date":"2015","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/25633098","citation_count":34,"is_preprint":false},{"pmid":"22402018","id":"PMC_22402018","title":"Implication of common and disease specific variants in CLU, CR1, and PICALM.","date":"2012","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/22402018","citation_count":32,"is_preprint":false},{"pmid":"25025927","id":"PMC_25025927","title":"The ERK/eIF4F/Bcl-XL pathway mediates SGP-2 induced osteosarcoma cells apoptosis in vitro and in vivo.","date":"2014","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/25025927","citation_count":32,"is_preprint":false},{"pmid":"7678201","id":"PMC_7678201","title":"Regulation of Sertoli cell alpha 2-macroglobulin and clusterin (SGP-2) secretion by peritubular myoid cells.","date":"1993","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/7678201","citation_count":31,"is_preprint":false},{"pmid":"27516739","id":"PMC_27516739","title":"Plasma Clusterin and the CLU Gene rs11136000 Variant Are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients.","date":"2016","source":"Frontiers in aging neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/27516739","citation_count":31,"is_preprint":false},{"pmid":"1781989","id":"PMC_1781989","title":"In vivo secretion and association of clusterin (SGP-2) in luminal fluid with spermatozoa in the rat testis and epididymis.","date":"1991","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/1781989","citation_count":31,"is_preprint":false},{"pmid":"8963451","id":"PMC_8963451","title":"Clusterin (SGP-2) induction in rat astroglial cells exposed to prion protein fragment 106-126.","date":"1996","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/8963451","citation_count":30,"is_preprint":false},{"pmid":"25496871","id":"PMC_25496871","title":"Alzheimer's disease risk variant in CLU is associated with neural inefficiency in healthy individuals.","date":"2014","source":"Alzheimer's & dementia : the journal of the Alzheimer's Association","url":"https://pubmed.ncbi.nlm.nih.gov/25496871","citation_count":30,"is_preprint":false},{"pmid":"36779631","id":"PMC_36779631","title":"CLU (clusterin) promotes mitophagic degradation of MSX2 through an AKT-DNM1L/Drp1 axis to maintain SOX2-mediated stemness in oral cancer stem cells.","date":"2023","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/36779631","citation_count":29,"is_preprint":false},{"pmid":"8440994","id":"PMC_8440994","title":"SP-40,40 immunoreactivity in inflammatory CNS lesions displaying astrocyte/oligodendrocyte interactions.","date":"1993","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/8440994","citation_count":29,"is_preprint":false},{"pmid":"36098834","id":"PMC_36098834","title":"The role and function of CLU in cancer biology and therapy.","date":"2022","source":"Clinical and experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36098834","citation_count":27,"is_preprint":false},{"pmid":"29262741","id":"PMC_29262741","title":"Liposomal co-delivery-based quantitative evaluation of chemosensitivity enhancement in breast cancer stem cells by knockdown of GRP78/CLU.","date":"2018","source":"Journal of liposome research","url":"https://pubmed.ncbi.nlm.nih.gov/29262741","citation_count":27,"is_preprint":false},{"pmid":"40311610","id":"PMC_40311610","title":"CLU alleviates Alzheimer's disease-relevant processes by modulating astrocyte reactivity and microglia-dependent synaptic density.","date":"2025","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/40311610","citation_count":26,"is_preprint":false},{"pmid":"24244428","id":"PMC_24244428","title":"CLU genetic variants and cognitive decline among elderly and oldest old.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24244428","citation_count":26,"is_preprint":false},{"pmid":"9056387","id":"PMC_9056387","title":"TRPM-2 expression and tunel staining in neurodegenerative diseases: studies in wobbler and rd mice.","date":"1997","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/9056387","citation_count":26,"is_preprint":false},{"pmid":"19879425","id":"PMC_19879425","title":"CLU \"in and out\": looking for a link.","date":"2009","source":"Advances in cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19879425","citation_count":25,"is_preprint":false},{"pmid":"21466683","id":"PMC_21466683","title":"CLU, CR1 and PICALM genes associate with Alzheimer's-related senile plaques.","date":"2011","source":"Alzheimer's research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/21466683","citation_count":25,"is_preprint":false},{"pmid":"37494190","id":"PMC_37494190","title":"Astrocytic response mediated by the CLU risk allele inhibits OPC proliferation and myelination in a human iPSC model.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37494190","citation_count":24,"is_preprint":false},{"pmid":"9203052","id":"PMC_9203052","title":"The effects of spinal cord injury on the status of messenger ribonucleic acid for TRPM 2 and androgen receptor in the prostate of the rat.","date":"1997","source":"Journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/9203052","citation_count":24,"is_preprint":false},{"pmid":"1660393","id":"PMC_1660393","title":"Assignment of a human serum glycoprotein SP-40,40 gene (CLI) to chromosome 8.","date":"1991","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1660393","citation_count":24,"is_preprint":false},{"pmid":"19878773","id":"PMC_19878773","title":"Chapter 5: Nuclear CLU (nCLU) and the fate of the cell.","date":"2009","source":"Advances in cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19878773","citation_count":23,"is_preprint":false},{"pmid":"24336744","id":"PMC_24336744","title":"SGP-2, an acidic polysaccharide from Sarcandra glabra, inhibits proliferation and migration of human osteosarcoma cells.","date":"2014","source":"Food & function","url":"https://pubmed.ncbi.nlm.nih.gov/24336744","citation_count":23,"is_preprint":false},{"pmid":"23841781","id":"PMC_23841781","title":"Expression of Clu and Tgfb1 during murine tooth development: effects of in-vivo transfection with anti-miR-214.","date":"2013","source":"European journal of oral sciences","url":"https://pubmed.ncbi.nlm.nih.gov/23841781","citation_count":23,"is_preprint":false},{"pmid":"9415971","id":"PMC_9415971","title":"Effect of heat shock treatment on the production of variant testosterone-repressed prostate message-2 (TRPM-2) mRNA in culture cells.","date":"1997","source":"Cell biochemistry and function","url":"https://pubmed.ncbi.nlm.nih.gov/9415971","citation_count":23,"is_preprint":false},{"pmid":"24379779","id":"PMC_24379779","title":"Age-dependent effect of Alzheimer's risk variant of CLU on EEG alpha rhythm in non-demented adults.","date":"2013","source":"Frontiers in aging neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24379779","citation_count":23,"is_preprint":false},{"pmid":"29396813","id":"PMC_29396813","title":"Association between CLU gene rs11136000 polymorphism and Alzheimer's disease: an updated meta-analysis.","date":"2018","source":"Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/29396813","citation_count":22,"is_preprint":false},{"pmid":"19879421","id":"PMC_19879421","title":"The role of clusterin (CLU) in malignant transformation and drug resistance in breast carcinomas.","date":"2009","source":"Advances in cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19879421","citation_count":22,"is_preprint":false},{"pmid":"11054633","id":"PMC_11054633","title":"Increased levels of clusterin (SGP-2) mRNA and protein accompany rat ventral prostate involution following finasteride treatment.","date":"2000","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/11054633","citation_count":21,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48553,"output_tokens":4070,"usd":0.103355},"stage2":{"model":"claude-opus-4-6","input_tokens":7537,"output_tokens":3517,"usd":0.188415},"total_usd":0.29177,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1988,\n      \"finding\": \"SP-40,40 (CLU/clusterin) is incorporated into the SC5b-9 soluble membrane attack complex of complement, functioning as an inhibitor of complement-mediated cytolysis by combining with the nascent C5b-7 complex to form a cytolytically inactive SC5b-7–SP-40,40 complex\",\n      \"method\": \"Protein purification, hemolysis inhibition assay, immunodepletion of SP-40,40 from serum followed by SC5b-9 reconstitution\",\n      \"journal\": \"The Journal of clinical investigation / International immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro functional reconstitution and inhibition assay, replicated across multiple labs (PMID:2454950, 2489042, 2150757)\",\n      \"pmids\": [\"2454950\", \"2489042\", \"2150757\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"The two chains (alpha and beta) of SP-40,40/CLU are encoded in a single open reading frame on the same mRNA and are generated post-synthetically by proteolytic cleavage of a biosynthetic precursor that contains a signal sequence for secretory export and six N-linked glycosylation sites\",\n      \"method\": \"cDNA cloning and sequence analysis, molecular characterization\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct molecular cloning and sequence determination of precursor structure\",\n      \"pmids\": [\"2721499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"SP-40,40/CLU is associated with high-density lipoproteins (HDL) in human plasma, with up to 40–60% of NA1/NA2 (SP-40,40) co-eluting with apolipoprotein A-I-containing HDL fractions\",\n      \"method\": \"Agarose gel filtration, FPLC, anti-apoA-I immunoaffinity chromatography, partial amino acid sequencing\",\n      \"journal\": \"Arteriosclerosis and thrombosis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple chromatographic methods in single lab\",\n      \"pmids\": [\"1903064\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"All 10 cysteine residues of SP-40,40/CLU form interchain (alpha–beta) disulfide bonds arranged in an antiparallel ladder-like structure; no free sulfhydryl groups are present, and the disulfide bond motif is unique among complement proteins\",\n      \"method\": \"Tryptic peptide mapping, HPLC separation, amino acid sequencing of disulfide-containing peptides, fluorometric detection with ABD-F\",\n      \"journal\": \"FEBS letters / Journal of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct biochemical determination of disulfide bonds by peptide mapping and sequencing, confirmed by two independent studies\",\n      \"pmids\": [\"1551440\", \"1491011\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Soluble amyloid-beta (Abeta) in cerebrospinal fluid is complexed with SP-40,40/CLU (apolipoprotein J) in vivo; the interaction was demonstrated by direct binding experiments with synthetic Abeta peptide and immunoprecipitation from CSF\",\n      \"method\": \"Direct binding assay with synthetic Abeta peptide, immunoprecipitation from CSF, amino acid sequencing, immunoreactivity with specific antibodies\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro direct binding plus in vivo immunoprecipitation from CSF\",\n      \"pmids\": [\"8328966\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Three patient-specific CLU mutations in the beta-chain (p.I303NfsX13, p.R338W, p.I360N) cause retention of CLU protein in the endoplasmic reticulum, reduced Golgi transport, and diminished secretion, demonstrating that the beta-chain disulfide bridge region is required for CLU heterodimerization and transit through the secretory pathway\",\n      \"method\": \"Immunocytochemistry, immunodetection, ELISA for secreted CLU, expression in HEK293T and HEK293 FLp-In cell lines\",\n      \"journal\": \"Molecular neurodegeneration\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (ICC, Western, ELISA) in two cell lines with multiple mutations\",\n      \"pmids\": [\"26179372\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TREM2 directly binds CLU/APOJ (and other apolipoproteins) as identified by unbiased protein microarray screen; TREM2 overexpression enhances CLU uptake in heterologous cells, Trem2 knockout microglia show reduced CLU internalization, and disease-associated TREM2 mutations impair this binding and uptake\",\n      \"method\": \"Protein microarray screen, Co-immunoprecipitation, cell uptake assays in heterologous cells and primary microglia, Trem2 knockout mouse microglia, human macrophages from TREM2 variant carriers\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — unbiased screen plus multiple orthogonal functional validation methods across cell types and human samples\",\n      \"pmids\": [\"27477018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"EZH2 directly represses CLU expression in neuroblastoma cells via H3K27me3 deposition at the CLU gene locus; EZH2 knockdown or pharmacological inhibition restores CLU expression, and EZH2-/- MEFs show elevated CLU mRNA\",\n      \"method\": \"RNAi knockdown of EZH2, pharmacological inhibition with 3-deazaneplanocin A, HDAC inhibitor treatment, ChIP for H3K27me3 and PRC2 components at CLU locus, comparison with EZH2-/- MEFs\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches (RNAi, pharmacology, ChIP, genetic KO) in same study\",\n      \"pmids\": [\"22068036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Secreted CLU (sCLU) activates AKT survival signaling, whereas intracellular CLU inhibits NF-κB transcriptional activity; intracellular CLU forms a physical complex with HSP60 in neuroblastoma cells, and HSP60 inactivates the tumor-suppressive function of intracellular CLU\",\n      \"method\": \"Immunoprecipitation (physical complex with HSP60), AKT activity assay, NF-κB reporter assay, subcellular fractionation, overexpression of secreted vs. intracellular CLU forms\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — single lab with Co-IP and functional reporter assays\",\n      \"pmids\": [\"22012253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Transient CLU overexpression in SV40-immortalized human prostate epithelial cells (PNT2) causes accumulation in G0/G1, slows cell cycle progression, decreases DNA synthesis, reduces ODC and AdoMetDC activities, and increases Gas1 mRNA, demonstrating a direct anti-proliferative function\",\n      \"method\": \"Transient transfection/overexpression, flow cytometry cell cycle analysis, [3H]-thymidine incorporation, enzyme activity assays, Northern blot\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean gain-of-function with multiple readouts in single lab\",\n      \"pmids\": [\"12082621\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CLU promotes mitophagy in oral cancer stem cells by activating AKT, which phosphorylates DNM1L/Drp1 at Ser616 to initiate mitochondrial fission; CLU-mediated mitophagy degrades MSX2, preventing its nuclear translocation and thereby sustaining SOX2-dependent stemness. CLU knockdown disrupts mitochondrial metabolism and sensitizes cells to cisplatin\",\n      \"method\": \"Gain-of-function and loss-of-function (CLU overexpression and shRNA knockdown), phospho-specific western blot for DNM1L-Ser616, mitophagy flux assays, mitochondrial superoxide measurement, nuclear/cytoplasmic fractionation for MSX2, SOX2 reporter, xenograft models\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (KO/OE, phospho-WB, fractionation) in single lab\",\n      \"pmids\": [\"36779631\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"SORL1 loss in human iPSC-derived neurons (but not astrocytes, microglia, or endothelial cells) causes a cell-type-specific reduction in CLU protein levels; this neuron-specific SORL1–CLU relationship is validated in postmortem brain. TGF-β/SMAD signaling modulates APOE (and by implication CLU) levels in a SORL1-dependent manner\",\n      \"method\": \"SORL1-null iPSC differentiation to multiple cell types, proteomics, ELISA, retromer rescue experiments, SMAD pathway modulation, postmortem brain validation\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple cell types and orthogonal validation including postmortem brain, single lab\",\n      \"pmids\": [\"37611586\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"The CLU rs11136000 C risk allele is a functional variant: TDP-43 preferentially binds the C allele to promote CLU expression; C/C astrocytes show elevated interferon response and CXCL10 secretion after cytokine treatment, which inhibits oligodendrocyte progenitor cell (OPC) proliferation and myelination\",\n      \"method\": \"CRISPR-Cas9 isogenic iPSC system, allele-specific TDP-43 binding assay, RNA-seq, CXCL10 ELISA, OPC co-culture myelination assay, human brain tissue validation\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — isogenic CRISPR system with multiple functional readouts and human brain validation\",\n      \"pmids\": [\"37494190\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CLU deficiency in astrocytes activates NF-κB-dependent signaling and increases complement C3 secretion; reduced astrocyte CLU leads to microglia-dependent reduction of synaptic density, increased microglial phagocytosis, and altered extracellular APOE and phospho-tau levels. CLU AD-risk alleles associate with reduced CLU protein and heightened inflammatory profiles in human plasma and brain\",\n      \"method\": \"Unbiased proteomics in CLU-deficient astrocytes, functional validation (NF-κB reporter, C3 ELISA), microglia-astrocyte co-culture synapse counting, phagocytosis assay, mouse models, human plasma and brain tissue analysis\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — unbiased proteomics plus multiple orthogonal functional assays across mouse and human systems\",\n      \"pmids\": [\"40311610\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"Clusterin (SGP-2) is secreted into the caput epididymal lumen, binds to spermatozoa in the caput, and then dissociates from sperm to be endocytosed by cells of the distal epididymal epithelium; testicular and epididymal forms differ in molecular weight and isoelectric point\",\n      \"method\": \"Micropuncture/microperfusion collection of luminal fluid, 2D Western blot, membrane protein extraction from spermatozoa at different epididymal regions\",\n      \"journal\": \"Molecular reproduction and development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization by fractionation and binding assay tied to functional implications in sperm maturation\",\n      \"pmids\": [\"1781989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Extracellular CLU/SGP-2 acts as a mediator of anti-TNF-induced cytotoxicity: exogenous SGP-2 reduces TNF sensitivity in LNCaP cells, and anti-SGP-2 antibody renders TNF-resistant PC3 cells sensitive to TNF-induced cell death; this effect is reversible by adding exogenous SGP-2\",\n      \"method\": \"Cell viability assay (trypan blue), antibody neutralization of secreted SGP-2, exogenous protein addition, Western blot of conditioned media\",\n      \"journal\": \"The Prostate\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, antibody neutralization + rescue experiment with defined cellular phenotype\",\n      \"pmids\": [\"10221563\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CLU (clusterin/apolipoprotein J/SP-40,40) is a secreted heterodimeric glycoprotein generated by proteolytic cleavage of a single-chain precursor; its alpha and beta chains are linked by a unique interchain disulfide ladder. Extracellularly, sCLU inhibits complement membrane-attack complex assembly, binds HDL and apolipoproteins, and is taken up by microglia via TREM2-dependent recognition of CLU-lipoprotein complexes; sCLU also complexes soluble amyloid-beta in CSF and activates AKT to promote cell survival. In astrocytes, CLU suppresses NF-κB/C3-dependent inflammatory signaling and limits microglial phagocytosis of synapses, with its expression regulated by TDP-43 binding to the rs11136000 risk allele and epigenetically silenced by EZH2. Intracellularly, CLU can be retained in the nucleus or ER, where it inhibits NF-κB, forms a complex with HSP60 that modulates its tumor-suppressive function, or—when mutated in its beta-chain disulfide region—is degraded rather than secreted. In cancer stem cells, CLU activates AKT→DNM1L/Drp1 Ser616 phosphorylation to drive mitophagy, thereby degrading MSX2 and sustaining SOX2-dependent stemness.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CLU (clusterin/apolipoprotein J/SP-40,40) is a secreted heterodimeric glycoprotein chaperone that functions as a broad extracellular proteostasis and cytoprotective factor, with roles spanning complement regulation, lipoprotein metabolism, amyloid-beta clearance, and neuroinflammatory control. The mature protein is generated by proteolytic cleavage of a single-chain precursor into disulfide-linked alpha and beta chains arranged in a unique antiparallel disulfide ladder; mutations in the beta-chain disulfide region cause ER retention and loss of secretion [PMID:2721499, PMID:1551440, PMID:26179372]. Extracellularly, sCLU inhibits complement membrane-attack complex assembly by sequestering nascent C5b-7, associates with HDL, complexes soluble amyloid-beta in CSF, activates AKT survival signaling, and is internalized by microglia via TREM2 [PMID:2454950, PMID:1903064, PMID:8328966, PMID:22012253, PMID:27477018]. In astrocytes, CLU suppresses NF-κB/complement C3-dependent inflammatory signaling to limit microglial synaptic phagocytosis, with its expression regulated by TDP-43 binding at the AD-risk SNP rs11136000 and epigenetically silenced by EZH2-mediated H3K27 trimethylation [PMID:40311610, PMID:37494190, PMID:22068036].\",\n  \"teleology\": [\n    {\n      \"year\": 1988,\n      \"claim\": \"Establishing CLU's first known function: the question of what SP-40,40 does in serum was answered by showing it inhibits complement-mediated cytolysis by incorporating into the soluble membrane-attack complex and inactivating nascent C5b-7.\",\n      \"evidence\": \"Protein purification, hemolysis inhibition assay, and immunodepletion/reconstitution of SC5b-9 from human serum\",\n      \"pmids\": [\"2454950\", \"2489042\", \"2150757\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of C5b-7 recognition unknown\", \"In vivo complement-regulatory role not demonstrated at this point\", \"Stoichiometry of SP-40,40 in SC5b-9 complex not fully defined\"]\n    },\n    {\n      \"year\": 1989,\n      \"claim\": \"The biosynthetic origin of CLU's two-chain structure was resolved: a single mRNA encodes both alpha and beta chains as a precursor that undergoes post-translational cleavage and N-linked glycosylation for secretory export.\",\n      \"evidence\": \"cDNA cloning and full-length sequence analysis from human liver\",\n      \"pmids\": [\"2721499\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the processing protease unknown\", \"Signals governing glycosylation site occupancy not characterized\"]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Two new biological contexts for CLU were established: association with HDL in plasma implicated CLU in lipoprotein metabolism, and its dynamic binding/release cycle on spermatozoa in the epididymis revealed a role in reproductive biology.\",\n      \"evidence\": \"FPLC/immunoaffinity chromatography of plasma lipoproteins; micropuncture/microperfusion and 2D Western blot of epididymal luminal fluid\",\n      \"pmids\": [\"1903064\", \"1781989\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of HDL association for lipid transport unclear\", \"Whether CLU on spermatozoa influences fertilization not tested\", \"Receptor mediating epididymal re-uptake unknown\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"The unique disulfide architecture of CLU was mapped: all 10 cysteines form interchain alpha–beta bonds in an antiparallel ladder, with no free sulfhydryls, establishing a structural hallmark distinct from other complement-associated proteins.\",\n      \"evidence\": \"Tryptic peptide mapping, HPLC, amino acid sequencing of disulfide peptides\",\n      \"pmids\": [\"1551440\", \"1491011\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No three-dimensional structure available\", \"Functional role of individual disulfide bonds not dissected\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"CLU was linked to Alzheimer's disease biology by demonstrating that soluble amyloid-beta in CSF is physically complexed with CLU, establishing CLU as an endogenous Aβ-binding chaperone.\",\n      \"evidence\": \"Direct binding assay with synthetic Aβ peptide and co-immunoprecipitation from human CSF\",\n      \"pmids\": [\"8328966\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CLU-Aβ complexation prevents or promotes amyloid deposition in vivo unknown\", \"Binding stoichiometry and affinity not quantified\", \"Receptor-mediated clearance of CLU-Aβ complex not identified\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Extracellular CLU was shown to confer cytoprotection against TNF-induced cell death: neutralizing secreted CLU sensitized resistant cancer cells to TNF, and exogenous CLU reversed this effect.\",\n      \"evidence\": \"Antibody neutralization of secreted CLU, exogenous protein rescue, cell viability assay in prostate cancer lines\",\n      \"pmids\": [\"10221563\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream signaling pathway mediating anti-TNF effect not identified\", \"Whether this reflects a general anti-apoptotic function or TNF-specific mechanism unclear\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"A direct anti-proliferative function for CLU was demonstrated: overexpression caused G0/G1 arrest, reduced DNA synthesis, and upregulated growth arrest gene Gas1, extending CLU's role beyond secreted chaperone to cell-autonomous growth regulation.\",\n      \"evidence\": \"Transient transfection in PNT2 prostate epithelial cells, flow cytometry, thymidine incorporation, enzyme activity assays\",\n      \"pmids\": [\"12082621\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking CLU to Gas1 upregulation unknown\", \"Whether the anti-proliferative effect requires secreted or intracellular CLU not distinguished\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Two studies resolved how CLU expression is regulated and how its secreted vs. intracellular forms differ functionally: EZH2 directly silences CLU via H3K27me3, while sCLU activates AKT and intracellular CLU inhibits NF-κB in a complex with HSP60.\",\n      \"evidence\": \"ChIP for H3K27me3/PRC2 at CLU locus with EZH2 knockdown/knockout; Co-IP of CLU-HSP60, AKT activity assay, NF-κB reporter assay in neuroblastoma cells\",\n      \"pmids\": [\"22068036\", \"22012253\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of kinase(s) downstream of sCLU-AKT activation unknown\", \"Physiological relevance of CLU-HSP60 complex outside neuroblastoma not tested\", \"Whether EZH2-mediated silencing operates in neurons or astrocytes unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"The functional requirement of the beta-chain disulfide region for CLU secretion was demonstrated: patient-derived mutations in this region cause ER retention and abolish heterodimerization, linking structural integrity to secretory pathway transit.\",\n      \"evidence\": \"Expression of three CLU point mutants in HEK293T/Flp-In cells, ICC co-localization with ER markers, ELISA for secreted CLU\",\n      \"pmids\": [\"26179372\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ER-retained CLU triggers unfolded protein response not examined\", \"In vivo consequences of these mutations in patient brain tissue not characterized\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"The receptor mediating microglial uptake of CLU was identified as TREM2: TREM2 directly binds CLU, Trem2 knockout microglia show impaired CLU internalization, and AD-associated TREM2 variants disrupt this interaction.\",\n      \"evidence\": \"Protein microarray screen, Co-IP, cell uptake assays in Trem2-KO primary microglia and human TREM2-variant macrophages\",\n      \"pmids\": [\"27477018\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TREM2-CLU interaction mediates Aβ clearance in vivo not demonstrated\", \"Structural basis of TREM2-CLU binding not resolved\", \"Contribution of other receptors (e.g., megalin/LRP2) to CLU uptake not excluded\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Three studies expanded CLU's mechanistic repertoire: in cancer stem cells CLU drives AKT→DNM1L/Drp1-dependent mitophagy to sustain SOX2 stemness; SORL1 controls neuron-specific CLU levels; and the AD-risk SNP rs11136000 C allele enhances CLU expression via TDP-43 binding, leading to astrocytic interferon/CXCL10 signaling that impairs myelination.\",\n      \"evidence\": \"CLU gain/loss-of-function with phospho-Drp1 and mitophagy flux assays in oral cancer stem cells and xenografts; SORL1-null iPSC-derived neurons with proteomics and postmortem validation; CRISPR-isogenic iPSC astrocytes with allele-specific TDP-43 binding, RNA-seq, and OPC co-culture myelination assay\",\n      \"pmids\": [\"36779631\", \"37611586\", \"37494190\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether AKT-Drp1-mitophagy axis operates outside oral cancer not tested\", \"Mechanism by which SORL1 regulates CLU protein specifically in neurons unclear\", \"TDP-43 binding to rs11136000 not validated in vivo\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"CLU's neuroinflammatory function was mechanistically defined: CLU deficiency in astrocytes activates NF-κB, elevates complement C3 secretion, and drives microglia-dependent synaptic loss via enhanced phagocytosis, directly linking reduced CLU to AD-related neurodegeneration.\",\n      \"evidence\": \"Unbiased proteomics in CLU-deficient astrocytes, NF-κB reporter, C3 ELISA, astrocyte-microglia co-culture synapse counting, mouse models, human plasma/brain validation\",\n      \"pmids\": [\"40311610\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CLU supplementation can rescue synaptic loss in vivo not shown\", \"Specific NF-κB subunit(s) regulated by CLU not identified\", \"Relative contribution of complement-dependent vs. independent microglial phagocytosis pathways not dissected\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the three-dimensional structure of CLU, the identity of the protease that cleaves the precursor into alpha/beta chains, the full receptor repertoire for CLU uptake across cell types, and whether restoring CLU levels in astrocytes or neurons can ameliorate neurodegeneration in vivo.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal or cryo-EM structure of CLU heterodimer\", \"Processing protease identity unknown\", \"Therapeutic potential of CLU modulation untested in neurodegeneration models\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 8, 13]},\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 2, 4, 14, 15]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 13]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [8, 10]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [15]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"complexes\": [\n      \"SC5b-9 (soluble membrane attack complex)\",\n      \"HDL particle\",\n      \"CLU-HSP60 complex\"\n    ],\n    \"partners\": [\n      \"TREM2\",\n      \"HSP60\",\n      \"TDP-43\",\n      \"SORL1\",\n      \"DNM1L\",\n      \"AKT1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}